Questionnaire

    Depression Risk Assessment

    A guided mood and symptom check to help you understand your emotional well-being.

    7-9 min
    10 Questions
    Instant Results

    Overview

    Depression affects over 280 million people worldwide. This assessment helps you understand your current mood patterns and identify symptoms that may indicate depressive tendencies. Early awareness is key to prevention and effective intervention.

    The Evolution of Depression Screening

    Depression screening has evolved significantly since Aaron Beck developed the Beck Depression Inventory (BDI) in 1961. The PHQ-9 (Patient Health Questionnaire-9), developed by Drs. Kroenke, Spitzer, and Williams in 2001, became the most widely used depression screening tool in primary care. Our assessment draws from these validated instruments to provide a quick, meaningful evaluation of depressive symptoms. Modern understanding recognizes depression as a complex interplay of genetic, neurochemical, cognitive, and environmental factors.

    How This Assessment Works

    1

    Reflect on Recent Weeks

    Rate 10 statements about your mood, energy, and daily functioning over the past two weeks.

    2

    Symptom Pattern Analysis

    Your responses are analyzed for key depressive symptom patterns including mood, energy, sleep, and cognition.

    3

    Risk Level Assessment

    Receive a clear interpretation of your symptom severity with contextual information.

    4

    Support & Resources

    Get matched with evidence-based coping strategies and guidance on when to seek professional help.

    What You'll Learn

    Your current depressive symptom severity

    Which symptom domains are most affected (mood, energy, sleep, appetite, cognition)

    Whether your symptoms suggest a need for professional evaluation

    Evidence-based self-help strategies appropriate for your level

    Resources for further support and treatment options

    The Science Behind This Assessment

    The PHQ-9 has been validated in numerous studies with a sensitivity of 88% and specificity of 88% for major depression. Depression involves changes in serotonin, norepinephrine, and dopamine neurotransmitter systems, as well as neuroplasticity changes in the hippocampus and prefrontal cortex.

    Frequently Asked Questions

    Ready to Discover Your Results?

    Take the Depression Risk Assessment now and receive your personalized report with actionable insights.